The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
88444482 8844448 2 F 20160802 20121017 20160807 EXP PHHY2012CN089485 NOVARTIS LOU S, LUO Y, ZENG H, SHEN Y, ZHANG P, CHEN L ET AL.. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING DONOR CIK CELL INFUSION: A PHASE 1 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES. LEUKEMIA RESEARCH. 2012;48:6-10 32.00 YR F Y 0.00000 20160808 OT CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
88444482 8844448 1 PS NEORAL CYCLOSPORINE 1 Intravenous (not otherwise specified) 2.5 MG/KG, QD 50715 2.5 MG/KG QD
88444482 8844448 2 SS NEORAL CYCLOSPORINE 1 Oral 5 MG/KG, UNK 50715 5 MG/KG
88444482 8844448 3 SS NEORAL CYCLOSPORINE 1 50715
88444482 8844448 4 SS NEORAL CYCLOSPORINE 1 50715
88444482 8844448 5 SS SIMULECT BASILIXIMAB 1 Unknown 20 MG, UNK 0 20 MG
88444482 8844448 6 SS SIMULECT BASILIXIMAB 1 0
88444482 8844448 7 SS SIMULECT BASILIXIMAB 1 0
88444482 8844448 8 SS SIMULECT BASILIXIMAB 1 0
88444482 8844448 9 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 15 MG/M2, DAY +1 0 15 MG/M**2
88444482 8844448 10 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 10 MG/M2, DAY +3 AND DAY +7 0 10 MG/M**2
88444482 8844448 11 SS METHOTREXATE. METHOTREXATE 1 0
88444482 8844448 12 SS METHOTREXATE. METHOTREXATE 1 0
88444482 8844448 13 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 0.5 G, BID 0 .5 G CAPSULE BID
88444482 8844448 14 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0 CAPSULE
88444482 8844448 15 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0 CAPSULE
88444482 8844448 16 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0 CAPSULE
88444482 8844448 17 C FLUDARABINE FLUDARABINE PHOSPHATE 1 Intravenous (not otherwise specified) 30 MG/M2, UNK 0 30 MG/M**2 INJECTION
88444482 8844448 18 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown 0
88444482 8844448 19 C BUSULFAN. BUSULFAN 1 Unknown 0 TABLET
88444482 8844448 20 C ANTITHYMOCYTE IMMUNOGLOBULIN THYMOCYTE IMMUNE GLOBULIN NOS 1 Intravenous (not otherwise specified) 2.5 MG/KG, QD 0 2.5 MG/KG INJECTION QD
88444482 8844448 21 C SULFAMETHOXAZOLE SULFAMETHOXAZOLE 1 Unknown 0 TABLET
88444482 8844448 22 C FLUCONAZOLE. FLUCONAZOLE 1 Unknown 0 TABLET
88444482 8844448 23 C ACYCLOVIR. ACYCLOVIR 1 Unknown 0 TABLET
88444482 8844448 24 C ALPROSTADIL. ALPROSTADIL 1 Unknown U 0
88444482 8844448 25 C HEPARIN HEPARIN SODIUM 1 Unknown 0
88444482 8844448 26 C URSODEOXYCHOLIC ACID URSODIOL 1 Unknown 0 TABLET
88444482 8844448 27 C MESNA. MESNA 1 Unknown 0
88444482 8844448 28 C FILGRASTIM FILGRASTIM 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
88444482 8844448 1 Stem cell transplant
88444482 8844448 2 Bone marrow transplant
88444482 8844448 3 Prophylaxis against graft versus host disease
88444482 8844448 4 Immunosuppressant drug therapy
88444482 8844448 5 Bone marrow transplant
88444482 8844448 6 Stem cell transplant
88444482 8844448 7 Prophylaxis against graft versus host disease
88444482 8844448 8 Immunosuppressant drug therapy
88444482 8844448 9 Stem cell transplant
88444482 8844448 10 Bone marrow transplant
88444482 8844448 11 Prophylaxis against graft versus host disease
88444482 8844448 12 Immunosuppressant drug therapy
88444482 8844448 13 Stem cell transplant
88444482 8844448 14 Bone marrow transplant
88444482 8844448 15 Prophylaxis against graft versus host disease
88444482 8844448 16 Immunosuppressant drug therapy
88444482 8844448 17 Bone marrow conditioning regimen
88444482 8844448 18 Bone marrow conditioning regimen
88444482 8844448 19 Bone marrow conditioning regimen
88444482 8844448 20 Bone marrow conditioning regimen
88444482 8844448 21 Prophylaxis
88444482 8844448 22 Prophylaxis
88444482 8844448 23 Prophylaxis
88444482 8844448 24 Prophylaxis
88444482 8844448 25 Prophylaxis
88444482 8844448 26 Prophylaxis
88444482 8844448 27 Prophylaxis
88444482 8844448 28 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
88444482 8844448 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
88444482 8844448 Cytomegalovirus infection
88444482 8844448 Pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found